In terms of angiogenesis and the epithelial–mesenchymal transition (EMT), both of which are critical events in lung cancer progression, curcumin has been found to inhibit both events through the suppression of the PI3K/Akt/mTOR pathway. Here, AKT1 is linked to lung carcinoma.